scispace - formally typeset
L

Luis M. Ruilope

Researcher at European University of Madrid

Publications -  891
Citations -  109166

Luis M. Ruilope is an academic researcher from European University of Madrid. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 94, co-authored 841 publications receiving 97778 citations. Previous affiliations of Luis M. Ruilope include Lund University & Mayo Clinic.

Papers
More filters
Journal ArticleDOI

Hypotension based on office and ambulatory monitoring blood pressure. Prevalence and clinical profile among a cohort of 70,997 treated hypertensives

TL;DR: In this large cohort of patients in usual daily practice, one in eight treated hypertensive patients are at risk of hypotension according to daytime BP, and two-thirds of them are not adequately identified with office BP, suggesting ABPM could be especially helpful for identifying ambulatory hypotension.
Journal ArticleDOI

Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure.

TL;DR: Preliminary data indicate that the combination of ACEi and ARA is not accompanied by a higher renal risk, and the good prognostic effects of aldosterone antagonists in HF does not seem to be related to intrarenal effects of these compounds with the exception of preventing potassium loss and hypokalemia.
Journal ArticleDOI

Eprosartan for the treatment of hypertension

TL;DR: Eprosartan is safe, effective and well-tolerated in long-term treatment, either as a monotherapy or in combination with other antihypertensive drugs such as hydrochlorothiazide.
Journal ArticleDOI

Physical exercise and epicardial adipose tissue: A systematic review and meta‐analysis of randomized controlled trials

TL;DR: Physical exercise interventions—particularly endurance training, with further evidence needed for other exercise modalities—appear as an effective strategy for reducing EAT in individuals with overweight/obesity, which supports their implementation for cardiovascular risk reduction.